Illumina, Inc. (LON:0J8Z)
London · Delayed Price · Currency is GBP · Price in USD 131.77
-2.11 (-1.58%)
Dec 31, 2025, 5:15 PM BST
Illumina Market Cap
Illumina has a market cap or net worth of 15.06 billion as of December 31, 2025. Its market cap has decreased by -17.66% in one year.
Market Cap
15.06B
Enterprise Value
16.02B
Revenue
3.20B
Ranking
n/a
PE Ratio
28.72
Stock Price
131.77
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from 174.80M to 15.06B, an increase of 8,512.81%. That is a compound annual growth rate of 19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 15.06B | -11.07% |
| Dec 31, 2024 | 16.93B | -2.48% |
| Dec 29, 2023 | 17.36B | -34.24% |
| Dec 30, 2022 | 26.40B | -39.89% |
| Dec 31, 2021 | 43.92B | 10.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| GSK plc | 72.45B |
| Haleon | 33.16B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.71B |
| HUTCHMED (China) | 1.69B |